Apr 19, 2023 | News

Join Qinecsa at 32nd Pharmacovigilance 2023, 26-27 April, Boston

Join Qinecsa at 32nd Pharmacovigilance 2023 to discuss the latest developments in pharmacovigilance, drug safety & risk management.
Our President, Humaira Qureshi, will present ‘Fit for future sourcing for pharmacovigilance’ where she will discuss the drivers for change in the pharmacovigilance industry, the challenges faced by PV teams, and how traditional models of delivery need to adapt to meet the evolving landscape.

Fit for future sourcing for pharmacovigilance
14:20
Wednesday 26 April

Get in touch to book a meeting with us at the event and find out how Qinecsa can help you meet the changing needs of the pharmacovigilance landscape.

Resources

Find out more

Signal & risk management

31.03.2023 | Fact sheets

Qinecsa provides tailored signal detection and risk management services for clinical and commercial products, including associated benefit-risk management activities. With diverse therapeutic expertise and industry-leading technology, our team support the breadth and...

CVW platform

31.03.2023 | Fact sheets

The Commonwealth Vigilance Workbench (CVW) signal detection platform spans the full spectrum of the signal management process to ensure all potential signals are tracked with clear prioritization. Robust data integration and functionality enables analysis of aggregate...

Compliant drug safety framework for early phase clinical trials

28.03.2023 | Case studies

A biotech had successfully completed Phase I clinical trials and was rapidly progressing into Phase II. Serious adverse event (SAE) volume was expected to significantly increase and therefore associated workload could not be managed in-house.Qinecsa established a...